Neofect Co.,Ltd Share Price

Equities

A290660

KR7290660000

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
1,180 KRW +0.08% Intraday chart for Neofect Co.,Ltd -0.76% -5.07%

Financials

Sales 2022 26.2B 19.05M 1.53B Sales 2023 26.61B 19.35M 1.55B Capitalization 43.53B 31.65M 2.53B
Net income 2022 -9.62B -6.99M -560M Net income 2023 -4.96B -3.61M -289M EV / Sales 2022 2.03 x
Net Debt 2022 26.41B 19.2M 1.54B Net Debt 2023 15.37B 11.17M 894M EV / Sales 2023 2.21 x
P/E ratio 2022
-2.79 x
P/E ratio 2023
-6.06 x
Employees 47
Yield 2022 *
-
Yield 2023
-
Free-Float 83.99%
More Fundamentals * Assessed data
Dynamic Chart
Neofect Co.,Ltd announced that it has received KRW 4.99999991 billion in funding from Scandi New Technology Association No. 278 CI
Neofect Co.,Ltd announced that it has received KRW 4.99999991 billion in funding from Kyowon Life, Inc., Scandi New Technology Association No. 278 CI
Neofect Co.,Ltd agreed to acquire Chunjee Agency Co.,Ltd. from Nam Ki Young and an unknown seller for KRW 4.6 billion. CI
Neofect Co.,Ltd announced that it expects to receive KRW 4.99999991 billion in funding from Scandi New Technology Association No. 278 CI
Neofect Co.,Ltd announced that it expects to receive KRW 2,999.999946 million in funding from Kyowon Life, Inc. CI
Neofect Co.,Ltd announced that it has received KRW 4.999999597 billion in funding CI
Neofect Co.,Ltd announced that it has received KRW 999.99927 million in funding from Kyowon Life, Inc. CI
Neofect Co.,Ltd announced that it expects to receive KRW 999.99927 million in funding from Kyowon Life, Inc. CI
Neofect Co.,Ltd announced that it has received KRW 4.999999224 billion in funding from Lxwidwin investment Fund 1, Scandi New Technology Association No. 278 CI
Neofect Co.,Ltd announced that it expects to receive KRW 5.999999302 billion in funding from Lxwidwin investment Fund 1 CI
Neofect Co.,Ltd announced that it expects to receive KRW 4.999999597 billion in funding CI
Neofect Co.,Ltd announced that it has received KRW 2.999999834 billion in funding CI
Neofect to Raise 3 Billion Won via Stock Sale MT
Neofect Co.,Ltd announced that it expects to receive KRW 2.999999834 billion in funding CI
Neofect Co.,Ltd announced that it has received KRW 6 billion in funding CI
More news
1 day+0.08%
1 week-0.76%
Current month-6.65%
1 month-8.31%
3 months-0.76%
6 months+1.11%
Current year-5.07%
More quotes
1 week
1 166.00
Extreme 1166
1 200.00
1 month
1 166.00
Extreme 1166
1 298.00
Current year
1 135.00
Extreme 1135
1 580.00
1 year
1 135.00
Extreme 1135
2 075.00
3 years
1 030.00
Extreme 1030
5 090.00
5 years
1 030.00
Extreme 1030
7 630.00
10 years
1 030.00
Extreme 1030
10 100.00
More quotes
Managers TitleAgeSince
Founder 49 03/06/10
Founder 46 03/06/10
Director of Finance/CFO 52 -
Members of the board TitleAgeSince
Director of Finance/CFO 52 -
Founder 46 03/06/10
Founder 49 03/06/10
More insiders
Date Price Change Volume
26/04/24 1,180 +0.08% 42,770
25/04/24 1,179 +0.26% 26,833
24/04/24 1,176 +0.34% 20,447
23/04/24 1,172 -0.42% 44,129
22/04/24 1,177 -1.01% 26,477

End-of-day quote Korea S.E., April 25, 2024

More quotes
NEOFECT Co.,Ltd is a Korea-based company mainly engaged in the production and sale of medical devices. Major products include upper extremity rehabilitation medical devices, cognitive rehabilitation medical devices, and Internet of Things (IoT) light emitting diode (LED) sunglass. The rehabilitation medical devices are sold under the name of RAPAEL. The loT LED sunglass is sold under the name of Chemion. The Company distributes its products within the domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A290660 Stock